Literature DB >> 10625938

Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells.

H Chen1, Z S Zhang, Y L Zhang, D Y Zhou.   

Abstract

It has been reported that curcumin (diferuloylmethane) could inhibit growth of several types of malignant cells both in vitro and in vivo. However, the mechanism of its action is unknown. In this study, we investigated the inhibitory effects of curcumin on human colon carcinoma cell (Lovo) growth and its mechanism of action in vitro by means of growth assay, colony formation assay, MTT assay, cell cycle and apoptosis analysis. Curcumin inhibited cell growth in a dose-dependent manner. The ability of Lovo cells treated with curcumin to form colonies was depressed. MTT test showed that curcumin was cytotoxic to cells. Lovo cells treated with curcumin were largely accumulated in S, G2/M phase which prevented cells from entering the next cell cycle. Apoptosis induced by curcumin was confirmed by characteristic ladders and cellular morphological changes. Curcumin can inhibit Lovo cells growth and the cellular mechanism responsible for the action is to arrest the cell cycle in S, G2/M phase and to induce apoptotic cell death.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10625938

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  43 in total

1.  Curcuminoids activate p38 MAP kinases and promote UVB-dependent signalling in keratinocytes.

Authors:  Elias E Ayli; Susanne Dugas-Breit; Weijie Li; Christine Marshall; Liang Zhao; Marc Meulener; Thomas Griffin; Joel M Gelfand; John T Seykora
Journal:  Exp Dermatol       Date:  2010-04-20       Impact factor: 3.960

Review 2.  Colorectal cancer: chemopreventive role of curcumin and resveratrol.

Authors:  Vaishali B Patel; Sabeena Misra; Bhaumik B Patel; Adhip P N Majumdar
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

3.  Anticancer effect of curcumin on human B cell non-Hodgkin's lymphoma.

Authors:  Chunyan Sun; Xinyue Liu; Yan Chen; Fang Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 4.  Cell cycle control as a basis for cancer chemoprevention through dietary agents.

Authors:  Syed Musthapa Meeran; Santosh Kumar Katiyar
Journal:  Front Biosci       Date:  2008-01-01

Review 5.  Curcumin and lung cancer--a review.

Authors:  Hiren J Mehta; Vipul Patel; Ruxana T Sadikot
Journal:  Target Oncol       Date:  2014-05-21       Impact factor: 4.493

6.  Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK.

Authors:  Nathan M Weir; Karuppaiyah Selvendiran; Vijay Kumar Kutala; Liyue Tong; Shilpa Vishwanath; Murugesan Rajaram; Susheela Tridandapani; Shrikant Anant; Periannan Kuppusamy
Journal:  Cancer Biol Ther       Date:  2007-02-05       Impact factor: 4.742

7.  Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma.

Authors:  Wibisono Hartojo; Amy L Silvers; Dafydd G Thomas; Christopher W Seder; Lin Lin; Hyma Rao; Zhuwen Wang; Joel K Greenson; Thomas J Giordano; Mark B Orringer; Alnawaz Rehemtulla; Mahaveer S Bhojani; David G Beer; Andrew C Chang
Journal:  Transl Oncol       Date:  2010-04       Impact factor: 4.243

Review 8.  Interacting inflammatory and growth factor signals underlie the obesity-cancer link.

Authors:  Laura M Lashinger; Nikki A Ford; Stephen D Hursting
Journal:  J Nutr       Date:  2013-11-27       Impact factor: 4.798

9.  Curcumin decreases the expression of Pokemon by suppressing the binding activity of the Sp1 protein in human lung cancer cells.

Authors:  Jiajun Cui; Xianfeng Meng; Xudong Gao; Guangxuan Tan
Journal:  Mol Biol Rep       Date:  2009-05-15       Impact factor: 2.316

10.  Overexpression of the ATP binding cassette gene ABCA1 determines resistance to Curcumin in M14 melanoma cells.

Authors:  Beatrice E Bachmeier; Cristina M Iancu; Peter H Killian; Emanuel Kronski; Valentina Mirisola; Giovanna Angelini; Marianne Jochum; Andreas G Nerlich; Ulrich Pfeffer
Journal:  Mol Cancer       Date:  2009-12-23       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.